Richard P. Shea

This profile gathers the share dealings of Richard P. Shea across 3 companies, led by Momenta Pharmaceuticals Inc, Syndax Pharmaceuticals Inc and Synlogic, Inc. Between 18 February 2016 and 26 April 2025, the trades on record add up to 22 filings.

Both buying and selling appear: 1 purchase worth €18k, against 16 sales worth €212k. The net balance comes to €193k on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 2 share grants.

The record was last updated on 29 April 2025 with a share grant in Synlogic, Inc. The latest purchase dates back some time: it was published 2,503 days ago, on 16 December 2019. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.